Sponsor
Logo of Improve Outcomes People
  Home | Forum | About Us | Links | Search | Site Map
 
CARF Accreditation Standards and Tools
Introduction
Disclaimer
Business Practices Standards
General Program Standards
Core Program Standards
JCAHO Accreditation Standards and Tools
Performance Measurement Tools
Practice Guidelines and Adherence Audit Tool
Outcome Measure Reports
Quality Improvement Process
Quality Improvement Tutorials
Online Courses
Evidence-Based Search

Sponsor
 
Medication Management
Printer Friendly
 
  CARF: Standards and ToolsSection 2: General Program Standards  
 

Medication Dosing Medication Dosing
The medications used in the treatment of opioid addiction (methadone, LAAM [levo-alpha-acetyl-methadol], and buprenorphine are those that are FDA approved) are used to stabilize clients, block euphoria, and eliminate withdrawal and craving. The initial dose of methadone should not exceed 30 mg of methadone and is individually determined by a physician following the history and physical examination. Dosing protocols are individualized.

 

Take-Home MedicationTake-Home Medication
The Medical Director, with input from members of the clinical team, determines if a person is eligible for unsupervised take-home medications based on specified criteria and length of time in the program.

 

Medically Supervised Withdrawal (MSW) Medically Supervised Withdrawal (MSW)
Medically Supervised Withdrawal (MSW) is the term used for detoxification from methadone, since methadone itself should not be considered a toxic substance. This procedure is designed to eliminate the withdrawal syndrome. MSW may occur for a variety of reasons, and it should be physician-directed, be documented appropriately, and include supportive services and/or referral if necessary.

 

 

 


Sponsor
 
  Contact Us | Disclaimer | Privacy | Accessibility
Report Web site problems to webmaster@improveoutcomes.com.
Copyright © 2006 Danya International, Inc. All rights reserved.